{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:28Z","timestamp":1792783168511,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal College of Surgeons in Ireland","id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To critically appraise and evaluate the safety and efficacy of intraoperative tranexamic acid (TXA) administration during transurethral resection of the prostate (TURP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of online databases was conducted to identify randomised-controlled trials (RCTs) which compared surgical outcomes and complication rates in patients undergoing TURP for benign prostatic hyperplasia (BPH) who were treated with TXA (intervention) as compared to placebo\/none (control). The efficacy of intraoperative TXA was evaluated through outcomes related to blood loss, rate of blood transfusion and operative time. The safety of TXA was evaluated through pooled analysis of both deep venous thrombosis and pulmonary emboli.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine RCTs met the inclusion criteria for this meta-analysis in which a total of 661 patients underwent TURP for BPH (331 TXA: 330 Control). There was significantly less intraoperative bleeding in the TXA group (MD \u201340.23\u00a0mL [95%CI \u201366.76 to \u201313.71],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), which was reflected in a significantly lesser haemoglobin drop on the first postoperative day (MD \u20130.55\u00a0g\/dL [95%CI \u20130.71 to \u20130.39],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001). TXA was associated with a significantly shorter operative time (MD \u20139.77\u00a0min [95%CI \u201316.97 to \u20132.58],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), with patients who received TXA exposed to a significantly reduced risk of blood transfusion (0.99% TXA vs. 7.69% Control, OR 0.16 [95%CI 0.03\u20130.93],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). There was no statistically significant increase in risk of DVT in the TXA group,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.46.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intraoperative administration of TXA is safe and effective in reducing intraoperative blood loss, operative time and postoperative haemoglobin (Hb) drop with resultant decrease in blood transfusion requirements. This meta-analysis did not detect any significant increase in venous thrombosis or risk of pulmonary embolism incurred by TXA administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05180-7","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:04:42Z","timestamp":1778155482000},"page":"4003-4014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of intraoperative tranexamic acid in transurethral resection of the prostate: a systematic review and meta-analysis of randomised-controlled trials"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-1447","authenticated-orcid":false,"given":"Cian M.","family":"Hehir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin G.","family":"Calpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon R.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry B.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"Suppl 3","key":"5180_CR1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ijir.2008.55","volume":"20","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG (2008) Pathology of benign prostatic hyperplasia. Int J Impot Res 20(Suppl 3):S11\u2013S18","journal-title":"Int J Impot Res"},{"issue":"1","key":"5180_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0022-5347(17)35405-8","volume":"150","author":"CG Chute","year":"1993","unstructured":"Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ et al (1993) The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150(1):85\u201389","journal-title":"J Urol"},{"issue":"1","key":"5180_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06628-8","volume":"7","author":"SWH Lee","year":"2017","unstructured":"Lee SWH, Chan EMC, Lai YK (2017) The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep 7(1):7984","journal-title":"Sci Rep"},{"issue":"1","key":"5180_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12894-025-01715-9","volume":"25","author":"H Wei","year":"2025","unstructured":"Wei H, Zhu C, Huang Q, Yang J, Li Y-T, Zhang Y-G et al (2025) Global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021 and projection to 2035. BMC Urol 25(1):34","journal-title":"BMC Urol"},{"issue":"9\u201310","key":"5180_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1159\/000517673","volume":"105","author":"J Herden","year":"2021","unstructured":"Herden J, Ebert T, Schlager D, Pretzer J, Porres D, Schafhauser W et al (2021) Perioperative outcomes of transurethral resection, open prostatectomy, and laser therapy in the surgical treatment of benign prostatic obstruction: a \u201creal-world\u201d data analysis from the URO-cert prostate centers. Urol Int 105(9\u201310):869\u2013874","journal-title":"Urol Int"},{"issue":"2","key":"5180_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bju.15653","volume":"130","author":"JVA Franco","year":"2022","unstructured":"Franco JVA, Jung JH, Imamura M, Borofsky M, Omar MI, Escobar Liquitay CM et al (2022) Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU Int 130(2):142\u2013156","journal-title":"BJU Int"},{"issue":"5","key":"5180_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP): incidence, management, and prevention. Eur Urol 50(5):969\u2013980","journal-title":"Eur Urol"},{"issue":"11","key":"5180_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/j.1464-410X.2009.09052.x","volume":"105","author":"T Fagerstr\u00f6m","year":"2010","unstructured":"Fagerstr\u00f6m T, Nyman CR, Hahn RG (2010) Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU Int 105(11):1560\u20131564","journal-title":"BJU Int"},{"issue":"5","key":"5180_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11934-022-01091-z","volume":"23","author":"N Ottaiano","year":"2022","unstructured":"Ottaiano N, Shelton T, Sanekommu G, Benson CR (2022) Surgical complications in the management of benign prostatic hyperplasia treatment. Curr Urol Rep 23(5):83\u201392","journal-title":"Curr Urol Rep"},{"issue":"3","key":"5180_CR10","first-page":"92","volume":"9","author":"AM O\u2019Donnell","year":"2009","unstructured":"O\u2019Donnell AM, Foo ITH (2009) Anaesthesia for transurethral resection of the prostate. Contin Educ Anaesth Crit Care Pain 9(3):92\u201396","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"5180_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urology.2024.05.015","volume":"191","author":"T Diab","year":"2024","unstructured":"Diab T, El Hamshary SA, Abou Elezz A, El-Dakhakhny AS (2024) Intraprostatic injection of tranexamic acid decrease blood loss during monopolar transurethral resection of the prostate: a randomized controlled clinical trial. Urology 191:119\u2013126","journal-title":"Urology"},{"issue":"2","key":"5180_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/2090598X.2022.2026011","volume":"20","author":"A Tawfick","year":"2022","unstructured":"Tawfick A, Mousa W, El-Zhary AF, Saafan AM (2022) Can tranexamic acid in irrigation fluid reduce blood loss during monopolar transurethral resection of the prostate? A randomised controlled trial. Arab J Urol 20(2):94\u201399","journal-title":"Arab J Urol"},{"issue":"3","key":"5180_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/bju.70117","volume":"137","author":"CM Hehir","year":"2026","unstructured":"Hehir CM, Calpin GG, Cullivan O, Daly GR, Dowling GP, Davis NF (2026) The role of 5-alpha reductase inhibitors in transurethral resection of the prostate: a meta-analysis of randomised controlled trials. BJU Int 137(3):430\u2013443","journal-title":"BJU Int"},{"issue":"4","key":"5180_CR14","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.surge.2022.11.005","volume":"21","author":"GG Calpin","year":"2023","unstructured":"Calpin GG, McAnena PF, Davey MG, Calpin P, Kerin MJ, McInerney N et al (2023) The role of tranexamic acid in reducing post-operative bleeding and seroma formation in breast surgery: a meta-analysis. Surgeon 21(4):e183\u2013e194","journal-title":"Surgeon"},{"issue":"10","key":"5180_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/bjs.9193","volume":"100","author":"K Ker","year":"2013","unstructured":"Ker K, Prieto-Merino D, Roberts I (2013) Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 100(10):1271\u20131279","journal-title":"Br J Surg"},{"issue":"21","key":"5180_CR16","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","volume":"386","author":"PJ Devereaux","year":"2022","unstructured":"Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI et al (2022) Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med 386(21):1986\u20131997","journal-title":"N Engl J Med"},{"key":"5180_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"5180_CR18","unstructured":"Training C (2020) Review Manager (RevMan) Computer program: Version 5.4. The Cochrane Collaboration"},{"issue":"3","key":"5180_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5173\/ceju.2011.03.art13","volume":"64","author":"S Kumsar","year":"2011","unstructured":"Kumsar S, Dirim A, Toks\u00f6z S, Sa\u011flam HS, Adsan O (2011) Tranexamic acid decreases blood loss during transurethral resection of the prostate (TURP). Cent European J Urol 64(3):156\u2013158","journal-title":"Cent European J Urol"},{"issue":"5","key":"5180_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.urology.2004.07.008","volume":"64","author":"A Rannikko","year":"2004","unstructured":"Rannikko A, P\u00e9tas A, Taari K (2004) Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology 64(5):955\u2013958","journal-title":"Urology"},{"issue":"1","key":"5180_CR21","first-page":"943","volume":"17","author":"QQ Meng","year":"2019","unstructured":"Meng QQ, Pan N, Xiong JY, Liu N (2019) Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate. Exp Ther Med 17(1):943\u2013947","journal-title":"Exp Ther Med"},{"issue":"98","key":"5180_CR22","first-page":"110","volume":"25","author":"A Mirmansouri","year":"2016","unstructured":"Mirmansouri A, Farzi F, Imantalab V, Khoshrang H, Biazar G, Khanjanian G et al (2016) A survey on the effects of intravenous tranexamic acid on the amount of transfusion in patients undergoing TURP. J Guilan Univ Med Sci 25(98):110\u2013116","journal-title":"J Guilan Univ Med Sci"},{"issue":"16","key":"5180_CR23","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/pros.24616","volume":"83","author":"W Vanderbruggen","year":"2023","unstructured":"Vanderbruggen W, Brits T, Tilborghs S, Derickx K, De Wachter S (2023) The effect of tranexamic acid on perioperative blood loss in transurethral resection of the prostate: a double-blind, randomized controlled trial. Prostate 83(16):1584\u20131590","journal-title":"Prostate"},{"issue":"1","key":"5180_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/2090598X.2021.1932125","volume":"20","author":"M Samir","year":"2022","unstructured":"Samir M, Saafan AM, Afifi RM, Tawfick A (2022) Can high-dose tranexamic acid have a role during transurethral resection of the prostate in large prostates? A randomised controlled trial. Arab J Urol 20(1):24\u201329","journal-title":"Arab J Urol"},{"issue":"16","key":"5180_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.purol.2017.09.008","volume":"27","author":"A Jendoubi","year":"2017","unstructured":"Jendoubi A, Malouch A, Bouzouita A, Riahi Y, Necib H, Ghedira S et al (2017) Int\u00e9r\u00eat de l\u2019acide tranexamique dans les r\u00e9sections endoscopiques urologiques: \u00e9tude prospective randomis\u00e9e. Prog Urol 27(16):1036\u20131042","journal-title":"Prog Urol"},{"issue":"2","key":"5180_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/2051415819855887","volume":"13","author":"B Karkhanei","year":"2020","unstructured":"Karkhanei B, Musavi-Bahar SH, Bayat M, Kaseb K, Rezaee H, Moradi A et al (2020) Safety and efficacy of intraoperative administration of intravenous tranexamic acid in transurethral resection of prostate: a double-blind, randomised, placebo-controlled trial. J Clin Urol 13(2):125\u2013131","journal-title":"J Clin Urol"},{"key":"5180_CR27","first-page":"66","volume":"7","author":"R Rani","year":"2018","unstructured":"Rani R, Mittal S, Choubey SK, Pipara G (2018) Use of tranexemic acid as a topical agent to reduce bleeding during TURP: a novel technique! Int J Sci Res 7:66\u201368","journal-title":"Int J Sci Res"},{"issue":"3","key":"5180_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/UA.UA_41_20","volume":"13","author":"A Gupta","year":"2021","unstructured":"Gupta A, Priyadarshi S, Vyas N, Sharma G (2021) Efficacy of tranexamic acid in decreasing primary hemorrhage in transurethral resection of the prostate: a novel combination of intravenous and topical approach. Urol Ann 13(3):238\u2013242","journal-title":"Urol Ann"},{"issue":"11","key":"5180_CR29","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1089\/end.2010.0174","volume":"24","author":"A Descazeaud","year":"2010","unstructured":"Descazeaud A, Azzousi AR, Ballereau C, Bruyere F, Robert G, Delongchamps NB et al (2010) Blood loss during transurethral resection of the prostate as measured by the chromium-51 method. J Endourol 24(11):1813\u20131816","journal-title":"J Endourol"},{"key":"5180_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5832","author":"S Padhi","year":"2015","unstructured":"Padhi S, Kemmis-Betty S, Rajesh S, Hill J, Murphy MF (2015) Blood transfusion: summary of NICE guidance. BMJ. https:\/\/doi.org\/10.1136\/bmj.h5832","journal-title":"BMJ"},{"issue":"2","key":"5180_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jamasurg.2025.5498","volume":"161","author":"LM Delgado","year":"2026","unstructured":"Delgado LM, Pompeu BF, Martins GHA, Azevedo ML, Pasqualotto E, Chulam TC et al (2026) Perioperative use of tranexamic acid in general surgery: a systematic review and meta-analysis. JAMA Surg 161(2):179\u2013187","journal-title":"JAMA Surg"},{"issue":"3","key":"5180_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/bja\/aew405","volume":"118","author":"NR Webster","year":"2017","unstructured":"Webster NR (2017) Stranger danger: mortality after transfusions. Br J Anaesth 118(3):280\u2013282","journal-title":"Br J Anaesth"},{"issue":"4","key":"5180_CR33","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.arth.2016.10.015","volume":"32","author":"RV Madsen","year":"2017","unstructured":"Madsen RV, Nielsen CS, Kallemose T, Husted H, Troelsen A (2017) Low risk of thromboembolic events after routine administration of tranexamic acid in hip and knee arthroplasty. J Arthroplasty 32(4):1298\u20131303","journal-title":"J Arthroplasty"},{"issue":"1","key":"5180_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6961540","volume":"2021","author":"D Reale","year":"2021","unstructured":"Reale D, Andriolo L, Gursoy S, Bozkurt M, Filardo G, Zaffagnini S (2021) Complications of tranexamic acid in orthopedic lower limb surgery: a meta-analysis of randomized controlled trials. BioMed Res Int 2021(1):6961540","journal-title":"BioMed Res Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05180-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05180-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:52:40Z","timestamp":1789631560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05180-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05180-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have declared no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"IRB approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}